Alpha Cognition price to book ratio ACOG
Market value divided by the book value of the company's net assets, since 2025.
- Today, Oct 23, 2026
- 3.4×
- Peer median
- 2.9×
Alpha Cognition's price to book ratio is 3.4× as of Oct 23, 2026.
The median for 10 healthcare stocks of a similar size is 2.9×.
Price to book ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.4× | 2.1× | 4.2× |
| 2025 | 4.0× | 1.6× | 5.0× |
Against its peers
Companies in Healthcare nearest Alpha Cognition's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| ACOGAlpha Cognition | 3.4× |
| PDEXPro DEX | 4.2× |
| PLXProtalix BioTherapeutics | 2.9× |
| NATRNatures Sunshine Products | 1.3× |
| ELMDElectromed | 4.1× |
| UTMDUtah Medical Products | 1.9× |
| INFUInfuSystem | 4.7× |
| KEQUKewaunee Scientific | 1.3× |
| ICCCImmucell | 3.0× |
| VMDViemed Healthcare | 2.6× |
| EMBCEmbecta | n/m |
| Peer median | 2.9× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Alpha Cognition
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.